全文获取类型
收费全文 | 192796篇 |
免费 | 2380篇 |
国内免费 | 73篇 |
专业分类
耳鼻咽喉 | 1278篇 |
儿科学 | 7209篇 |
妇产科学 | 3509篇 |
基础医学 | 19168篇 |
口腔科学 | 1808篇 |
临床医学 | 14385篇 |
内科学 | 34205篇 |
皮肤病学 | 1238篇 |
神经病学 | 18197篇 |
特种医学 | 9330篇 |
外科学 | 30424篇 |
综合类 | 2462篇 |
一般理论 | 20篇 |
预防医学 | 20077篇 |
眼科学 | 3044篇 |
药学 | 10501篇 |
中国医学 | 659篇 |
肿瘤学 | 17735篇 |
出版年
2024年 | 42篇 |
2023年 | 279篇 |
2022年 | 505篇 |
2021年 | 963篇 |
2020年 | 588篇 |
2019年 | 773篇 |
2018年 | 22613篇 |
2017年 | 17891篇 |
2016年 | 20101篇 |
2015年 | 1583篇 |
2014年 | 1638篇 |
2013年 | 1842篇 |
2012年 | 8484篇 |
2011年 | 22493篇 |
2010年 | 19521篇 |
2009年 | 12168篇 |
2008年 | 20499篇 |
2007年 | 22692篇 |
2006年 | 1439篇 |
2005年 | 3032篇 |
2004年 | 4162篇 |
2003年 | 5033篇 |
2002年 | 3082篇 |
2001年 | 356篇 |
2000年 | 474篇 |
1999年 | 249篇 |
1998年 | 315篇 |
1997年 | 302篇 |
1996年 | 159篇 |
1995年 | 175篇 |
1994年 | 156篇 |
1993年 | 103篇 |
1992年 | 78篇 |
1991年 | 132篇 |
1990年 | 166篇 |
1989年 | 99篇 |
1988年 | 74篇 |
1987年 | 65篇 |
1986年 | 41篇 |
1985年 | 59篇 |
1984年 | 48篇 |
1983年 | 46篇 |
1982年 | 44篇 |
1981年 | 30篇 |
1980年 | 60篇 |
1978年 | 32篇 |
1938年 | 60篇 |
1934年 | 32篇 |
1932年 | 56篇 |
1930年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Ramona A. Cole Anita Bansal Debra M. Moriarity William A. Haber William N. Setzer 《Journal of natural medicines》2007,61(4):414-417
The leaf essential oil of Eugenia zuchowskiae from Monteverde, Costa Rica, has been obtained by hydrodistillation and analyzed by GC–MS. The principal constituents of
E. zuchowskiae leaf oil were α-pinene (28.3%), β-caryophyllene (13.2%), α-humulene (13.1%), and α-copaene (8.1%). The leaf essential oil
of E. zuchowskiae showed pronounced in-vitro cytotoxic activity against MCF-7, MDA-MB-468, and UACC-257 human tumor cell lines. The major components
showed cytotoxic activities comparable to doxorubicin (LC50 14–70 μg/ml). 相似文献
102.
103.
104.
105.
G. Vacca E. Marano V. Brescia Morra R. Lanzillo M. De Vito E. Parente G. Orefice 《Neurological sciences》2007,28(3):133-135
The prevalence of primary headache (PH) in a multiple sclerosis (MS) sample vs. control healthy subjects was investigated at a neurological clinic in 2004–2005: 122 of 238 (51%) MS patients and 57 of
238 (23%) controls proved to be affected by headache. The groups did not differ for the rates of PH types. Headache types
of MS patients were comparable to those of PH patients that were observed at the same institute in a case-control comparison.
First symptoms of headache preceded those of MS in two thirds of cases. Headache features did not significantly change after
MS onset. Comorbidity of MS and PH could be explained by some common clinical and biological traits. 相似文献
106.
Telma L F Gouveia Julia F O Paim Rita C Pavanello Mayana Zatz Mariz Vainzof 《Diagnostic molecular pathology》2006,15(2):95-100
Sarcoglycanopathies (SGpathies) are highly frequent among severely affected limb-girdle muscular dystrophy patients. On the basis of the findings of 5 common mutations in the 4 sarcoglycan (SG) genes in the Brazilian population, we standardized a multiplex polymerase chain reaction-single-strand conformation polymorphism methodology for their concomitant analysis in DNA samples. The test was able to confirm the diagnosis in about 63% of new patients with a suspected SGpathy and was particularly important in patients in advanced stages of the disease, when obtaining a muscle biopsy for analysis may be very difficult. As common mutations have been described in several countries, this multiplex analysis could be useful for the diagnosis of SGpathies if established according to the most prevalent mutations in each population. Besides, even though the disorder studied is rare, the technique could be broadly applicable to other genes and disorders. 相似文献
107.
Volker Heinemann 《Breast cancer research and treatment》2003,81(1):43-48
Single-agent chemotherapy of metastatic breast cancer is the treatment of choice in patients with slow tumor progression and asymptomatic disease. In this patient group, the choice of drugs is based more on good tolerability than on efficacy. By contrast, symptomatic or rapidly progressing disease requires the use of highly active regimens where more weight is put on reliable antitumor activity. While anthraycline-based combination regimens have set the standard of effective treatment, the addition of docetaxel (and to a lesser extent paclitaxel) has improved tumor response, but failed to induce a consistent prolongation of survival. Based on retrospective analyses, it is hypothesised that the combined use of anthracyclines and taxanes in first-line therapy may be most beneficial in defined subgroups: after adjuvant chemotherapy, in patients with HER-2 gene amplification, possibly also in patients with rapidly progressing visceral disease. 相似文献
108.
109.
Ohne Zusammenfassung 相似文献
110.